Friday, July 10, 2026

Semiconductor Stocks Slump After Reports of Potential Trump Tariffs

Nvidia's stock dropped nearly 3% as the Trump administration considers tariffs on semiconductors, causing a broad decline in the sector.

LG Chem Eyes China-Free Supply Chain to Avoid FEOC Designation

LG Chem is considering adjusting its stake in a Gumi plant due to U.S. regulations, aiming for a China-free supply chain.

Bitcoin moves sideways in $78,000 range amid Middle East uncertainty; all eyes on U.S. FOMC message

Bitcoin trades around $78,000 amid U.S.-Iran uncertainty, while upcoming Fed meeting may influence market direction.

Tag: NRAS mutations

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Belvarafenib: The Promising New Targeted Cancer Drug for NRAS Mutant Melanoma

Hanmi Pharmaceutical presents Belvarafenib's phase 2 trial for NRAS mutant melanoma at KCA 2026, targeting unmet medical needs.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.